The Men’s Health Lab Panel: What to Test and How Often

Most men have never seen their own bloodwork. They go to the doctor when something is visibly wrong, get told their numbers are “normal,” and leave without understanding what was actually measured or what those numbers mean for long-term health. A proactive lab panel changes that. It gives you a baseline, helps you track changes over time, and identifies problems years before they become symptomatic. This is not about hypochondria; it is about having data.

Why Lab Testing Matters for Men

Men are statistically less likely than women to seek preventive medical care ( 1 ). This is not a trivial gap. Conditions like type 2 diabetes, cardiovascular disease, hypogonadism, and thyroid dysfunction are frequently asymptomatic in early stages. By the time symptoms appear, meaningful damage has often already accumulated ( 2 ). Regular lab testing is the primary mechanism for catching these conditions in their reversible or manageable phases.

Testosterone-related conditions are a particular blind spot. Many men with clinically low testosterone attribute their symptoms, fatigue, low libido, mood changes, difficulty with body composition, to stress or aging and never get tested. A simple blood panel changes the entire diagnostic picture. For background on what low testosterone looks like clinically, see our overview of low testosterone in men.

The Science Behind Biomarker Monitoring

Why “Normal” Is Not the Same as Optimal

Standard lab reference ranges are population-based. They reflect what is common, not what is ideal for function and longevity. A testosterone level at the bottom of the reference range is technically “normal” but may still produce significant symptoms ( 3 ). The same logic applies to fasting glucose, lipid panels, and inflammatory markers. Tracking your own trend over time is more informative than a single comparison against a population average.

The Role of Inflammation and Metabolic Markers

Research increasingly points to chronic low-grade inflammation as a driver of cardiovascular disease, insulin resistance, and hormonal dysfunction ( 4 ). Markers like high-sensitivity C-reactive protein (hsCRP) and fasting insulin provide early signals of metabolic stress that standard lipid panels may miss. Including these in a comprehensive panel gives a more complete picture of systemic health ( 5 ).

What to Include in a Men’s Health Lab Panel

Hormonal Panel

  • Total testosterone: The most common entry point. Should be drawn in the morning when levels peak ( 6 ).
  • Free testosterone: The biologically active fraction. Total testosterone can be normal while free testosterone is suppressed due to elevated sex hormone-binding globulin (SHBG) ( 7 ).
  • SHBG: Binds testosterone and reduces bioavailability. Elevated SHBG is common in older men and in men with certain metabolic conditions.
  • LH and FSH: Luteinizing hormone and follicle-stimulating hormone indicate whether low testosterone is primary (testicular) or secondary (pituitary/hypothalamic) in origin ( 8 ).
  • Estradiol (E2): Elevated estradiol in men is associated with gynecomastia, reduced libido, and mood changes ( 9 ).
  • DHEA-S: A precursor hormone that declines with age. Low levels are associated with fatigue and reduced resilience to stress ( 10 ).
  • Thyroid panel (TSH, Free T3, Free T4): Thyroid dysfunction frequently mimics low testosterone symptoms and is often missed without a full panel ( 11 ).

Metabolic and Cardiovascular Panel

  • Fasting glucose and HbA1c: HbA1c reflects average blood sugar over three months, making it more informative than a single fasting reading ( 12 ).
  • Fasting insulin: Elevated fasting insulin indicates insulin resistance before glucose levels rise. This is one of the earliest metabolic warning signs ( 13 ).
  • Full lipid panel with LDL particle size: Small dense LDL particles carry greater cardiovascular risk than large buoyant particles, even at the same total LDL ( 14 ).
  • hsCRP: A sensitive marker of systemic inflammation. Levels above 1 mg/L are associated with increased cardiovascular risk ( 15 ).
  • Homocysteine: Elevated levels are an independent risk factor for cardiovascular disease and are often addressable through nutritional intervention ( 16 ).

Complete Blood Count and Organ Function

  • CBC (Complete Blood Count): Screens for anemia, immune abnormalities, and platelet disorders.
  • CMP (Comprehensive Metabolic Panel): Covers kidney function (creatinine, BUN), liver enzymes (AST, ALT), and electrolyte balance.
  • Vitamin D (25-OH): Deficiency is widespread in men and is associated with reduced testosterone, poor immune function, and increased depression risk ( 17 ).
  • Ferritin: Iron storage marker. Both deficiency and excess carry health consequences that a standard CBC may not reveal.

How Often to Test

For healthy men with no known conditions, an annual comprehensive panel is a reasonable baseline. Men over 40 benefit from adding testosterone and metabolic markers if not already included. Men with existing conditions, those on testosterone replacement therapy, or those making significant lifestyle interventions may benefit from testing every three to six months to track response ( 18 ). The goal is trend data, not single data points.

Common Mistakes Men Make

The most common mistake is requesting only a testosterone total and treating that as a full hormonal workup. Total testosterone alone is insufficient. Without free testosterone and SHBG, it is impossible to assess bioavailable hormone levels accurately ( 19 ).

A second mistake is testing at the wrong time of day. Testosterone follows a circadian rhythm, peaking in the morning. Afternoon testing can produce artificially low readings that lead to unnecessary clinical concern or missed diagnosis ( 20 ).

A third mistake is treating a one-time normal result as a permanent clearance. Biomarkers change with age, body composition, stress load, sleep quality, and lifestyle. Annual re-testing preserves the ability to catch changes before they become problems.

When to See a Doctor

Any man experiencing symptoms of hormonal imbalance, metabolic dysfunction, or unexplained changes in energy, mood, or body composition should seek a full lab panel. Do not wait for symptoms to become severe. Many of the conditions these panels detect are highly treatable when caught early.

If your results show low testosterone, understanding the treatment landscape is the logical next step. Our article on testosterone replacement therapy covers how physicians approach treatment decisions based on lab findings.

If your results flag depression alongside hormonal abnormalities, that combination warrants integrated evaluation. See our piece on the relationship between low testosterone and depression for clinical context.

Know Your Numbers

A lab panel is not a medical event; it is a data collection exercise. The more consistently you do it, the more useful the data becomes. Talk to your physician about building a testing cadence that fits your age, risk profile, and health goals. If your current doctor does not offer a comprehensive panel, consider a direct-to-consumer lab service or a men’s health clinic that specializes in proactive monitoring. Your numbers are yours to know.

Emergency Notice: If you or someone else is experiencing a medical emergency, call 911 immediately. The information on this site is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

References

  1. Bertakis KD, Azari R, Helms LJ, Callahan EJ, Robbins JA. Gender differences in the utilization of health care services. J Fam Pract. 2000;49(2):147-152. https://pubmed.ncbi.nlm.nih.gov/10718692/
  2. Pinkhasov RM, Wong J, Kashanian J, et al. Are men shortchanged on health? Perspective on health care utilization and health risk behavior in men and women in the United States. Int J Clin Pract. 2010;64(4):475-487. https://doi.org/10.1111/j.1742-1241.2009.02290.x
  3. Bhasin S, Brito JP, Cunningham GR, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://doi.org/10.1210/jc.2018-00229
  4. Ridker PM. C-Reactive Protein: Eighty Years from Discovery to Emergence as a Major Risk Marker for Cardiovascular Disease. Clin Chem. 2009;55(2):209-215. https://doi.org/10.1373/clinchem.2008.119214
  5. Emerging Risk Factors Collaboration; Kaptoge S, Di Angelantonio E, et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet. 2010;375(9709):132-140. https://doi.org/10.1016/S0140-6736(09)61717-7
  6. Brambilla DJ, Matsumoto AM, Araujo AB, McKinlay JB. The effect of diurnal variation on clinical measurement of serum testosterone and other sex hormone levels in men. J Clin Endocrinol Metab. 2009;94(3):907-913. https://doi.org/10.1210/jc.2008-1560
  7. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab. 1999;84(10):3666-3672. https://doi.org/10.1210/jcem.84.10.6079
  8. Boehm U, Bouloux PM, Dattani MT, et al. Expert consensus document: European Consensus Statement on congenital hypogonadotropic hypogonadism — pathogenesis, diagnosis and treatment. Nat Rev Endocrinol. 2015;11(9):547-564. https://doi.org/10.1038/nrendo.2015.112
  9. Finkelstein JS, Lee H, Burnett-Bowie SA, et al. Gonadal steroids and body composition, strength, and sexual function in men. N Engl J Med. 2013;369(11):1011-1022. https://doi.org/10.1056/NEJMoa1206168
  10. Orentreich N, Brind JL, Rizer RL, Vogelman JH. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab. 1984;59(3):551-555. https://doi.org/10.1210/jcem-59-3-551
  11. Bauer M, Goetz T, Glenn T, Whybrow PC. The thyroid-brain interaction in thyroid disorders and mood disorders. J Neuroendocrinol. 2008;20(10):1101-1114. https://doi.org/10.1111/j.1365-2826.2008.01774.x
  12. American Diabetes Association. Standards of Medical Care in Diabetes — 2023. Diabetes Care. 2023;46(Suppl 1):S1-S291. https://doi.org/10.2337/dc23-S001
  13. Reaven GM. Banting Lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37(12):1595-1607. https://doi.org/10.2337/diab.37.12.1595
  14. Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol. J Am Coll Cardiol. 2019;73(24):e285-e350. https://doi.org/10.1016/j.jacc.2018.11.003
  15. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997;336(14):973-979. https://doi.org/10.1056/NEJM199704033361401
  16. Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA. 2002;288(16):2015-2022. https://doi.org/10.1001/jama.288.16.2015
  17. Pilz S, Frisch S, Koertke H, et al. Effect of vitamin D supplementation on testosterone levels in men. Horm Metab Res. 2011;43(3):223-225. https://doi.org/10.1055/s-0030-1269854
  18. Morales A, Bebb RA, Manjoo P, et al. Diagnosis and management of testosterone deficiency syndrome in men: clinical practice guideline. CMAJ. 2015;187(18):1369-1377. https://doi.org/10.1503/cmaj.150033
  19. Zitzmann M, Faber S, Nieschlag E. Association of specific symptoms and metabolic risks with serum testosterone in older men. J Clin Endocrinol Metab. 2006;91(11):4335-4343. https://doi.org/10.1210/jc.2006-0401
  20. Brambilla DJ, Matsumoto AM, Araujo AB, McKinlay JB. The effect of diurnal variation on clinical measurement of serum testosterone and other sex hormone levels in men. J Clin Endocrinol Metab. 2009;94(3):907-913. https://doi.org/10.1210/jc.2008-1560